Novo Nordisk Regional Head due today
Tuesday, 4 December 2012
FE Report
World's largest Danish insulin manufacturer Novo Nordisk International Operations Vice President Mr. Maziar Mike Doustdar is scheduled to arrive in Dhaka today (Tuesday) for a short visit.
Mr. Mike Doustdar is responsible for Novo Nordisk operations in 21 countries including Bangladesh, ASEAN countries, Australia and New Zealand. During his stay he will be attending the launch program of Global Brands, Global Quality Insulins Manufactured in Bangladesh on the eve of 50 Years of Novo Nordisk in Bangladesh along with the Adviser to the Prime Minister of International Affairs, State Minister of the Ministry of Health and Family Welfare of Bangladesh, Danish Minister for Trade and Investment, Danish Ambassador, President of Diabetic Association of Bangladesh and Mr. Latifur Rahman, Chairman and CEO of Transcom Group.
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,900 employees in 75 countries, and markets its products in 190 countries. In Bangladesh Novo Nordisk has been working for changing diabetes over 50 years.
World's largest Danish insulin manufacturer Novo Nordisk International Operations Vice President Mr. Maziar Mike Doustdar is scheduled to arrive in Dhaka today (Tuesday) for a short visit.
Mr. Mike Doustdar is responsible for Novo Nordisk operations in 21 countries including Bangladesh, ASEAN countries, Australia and New Zealand. During his stay he will be attending the launch program of Global Brands, Global Quality Insulins Manufactured in Bangladesh on the eve of 50 Years of Novo Nordisk in Bangladesh along with the Adviser to the Prime Minister of International Affairs, State Minister of the Ministry of Health and Family Welfare of Bangladesh, Danish Minister for Trade and Investment, Danish Ambassador, President of Diabetic Association of Bangladesh and Mr. Latifur Rahman, Chairman and CEO of Transcom Group.
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,900 employees in 75 countries, and markets its products in 190 countries. In Bangladesh Novo Nordisk has been working for changing diabetes over 50 years.